The holidays came early for the pharmaceutical industry this year.
With Donald Trump elected to the White House and Republicans controlling Congress, the companies that make your medicines can expect a friendlier environment in which to operate. And investors quickly responded by boosting drug and biotech stocks.
So what lies ahead? Here are a few predictions:
FDA will stand for Faster Drug Approvals
Many Republicans would like to speed the Food and Drug Administration process for getting new medicines to patients. That’s going to remain a high priority.
